This chemical, CH5138303, is primarily utilized in pharmacological research to investigate the mechanisms of action of substances on the central nervous system. It holds potential for developing treatments for neurological disorders, such as Parkinson's disease or Alzheimer's disease. Preliminary studies indicate possibilities for its use in enhancing memory and learning. However, it remains in the experimental stage, requiring further research to confirm its efficacy and safety before application in humans. Additionally, it serves as a key intermediate in pharmaceutical research and development for synthesizing novel therapeutic agents, leveraging its unique structural properties to target specific biological pathways like enzyme inhibition or receptor modulation. It is also employed in organic chemistry laboratories for preparing complex molecules and studying reaction mechanisms.